EXEL EXELIXIS, INC.
Research report · from SEC EDGAR · close 2026-07-13
$56.04 -0.8%
$14.09B mkt cap
executive summary
EXELIXIS, INC. (EXEL) is a $14.09B company. Revenue is $2.32B (+7.0% y/y) at a 34% net margin. It is profitable. Our health score is A (87/100). No major red flags on file. Held by 1 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$2.32B
+7.0% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 9
Cash & ST investments
$777.2M
Operating cash flow
$884.3M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.